HMY
HARMONY GOLD MINING CO LTD
$15.34
-2.36%
$9.7B
No data for this timeframe.
Vol
Market Cap$9.7B
Cap SizeMid Cap
Inst. Holders6 funds
Inst. Value$54.2M
Inst. Activity2 buys / 1 sells
SEC Reports1
Recent Activity
Mar 26, 2026
SEC
Harmony Gold Mining announced a fatality at its Target 1 mine in South Africa due to an underground incident involving r
6-K — Impact 6/10
Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
1,176,120 shares ($23.4M)
Inst.
WELLS FARGO & COMPANY/MN — DOUBLED
195,546 shares ($3.9M)
Jun 9, 2026
short_volume
Short Volume: HMY — 61.1% short (0.7M / 1.2M)
Short: 710,592 | Exempt: 25 | TRF Vol: 1,162,084 | Short Ratio: 61.1% | Off-exchange volume (dark po
Price Targets
Historical data — last covering-analyst action Oct 2025. No current recommendation available.
$23.01 (Oct 2025)
Current $15.02
Low $20.04
Median $22.00
High $27.00
3 analysts
$20.04
$27.00
Analyst Ratings
2Strong Buy
7Buy
2Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2025 | HSBC | UPGRADE | Hold → Buy |
| Jul 17, 2025 | BMO Capital | INITIATE | Market Perform |
| Nov 12, 2024 | JP Morgan | MAINTAIN | Neutral → Neutral |
| Oct 10, 2024 | JP Morgan | UPGRADE | Underweight → Neutral |
| Jul 3, 2024 | JP Morgan | MAINTAIN | Underweight → Underweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $2.85 ▲ +1.6% | $2.74 — $2.96 | 121% YoY | 2 |
| Next FY | $3.32 | $3.32 — $3.32 | 16% YoY | 1 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $23.4M | DOUBLED |
| MORGAN STANLEY | $19.1M | TRIM |
| BANK OF AMERICA CORP | $6.0M | TRIM |
| WELLS FARGO & COMPANY/MN | $3.9M | DOUBLED |
| TWO SIGMA INVESTMENTS, LP | $1.5M | TRIM |
6 institutional holders with $54.2M total value (2,721,282 shares) as of 2025-Q4. Top holders: RENAISSANCE, MORGAN, BANK. Net buying activity: 2 institutions added/increased vs 1 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 1,176,120 | $23.4M | 43.2% | DOUBLED +775.6% |
| 2 | MORGAN STANLEY | 959,380 | $19.1M | 35.3% | TRIM -48.9% |
| 3 | BANK OF AMERICA CORP /DE/ | 299,000 | $6.0M | 11.0% | TRIM -42.2% |
| 4 | WELLS FARGO & COMPANY/MN | 195,546 | $3.9M | 7.2% | DOUBLED +101.5% |
| 5 | TWO SIGMA INVESTMENTS, LP | 75,546 | $1.5M | 2.8% | TRIM -57.3% |
| 6 | FMR LLC | 15,690 | $312.2K | 0.6% | TRIM -28.5% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 134,320 | 1,176,120 | +775.6% | $23.4M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 97,064 | 195,546 | +101.5% | $3.9M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 176,801 | 75,546 | -57.3% | $1.5M | 2025-Q4 |
| MORGAN STANLEY | TRIM | 2,190,676 | 1,118,931 | -48.9% | $20.3M | 2025-Q3 |
| UBS Group AG | ADD | 289,345 | 547,806 | +89.3% | $9.9M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 684,612 | 395,975 | -42.2% | $7.2M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 280,733 | 176,801 | -37.0% | $3.2M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 750,447 | 134,320 | -82.1% | $2.4M | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | ADD | 73,014 | 97,064 | +32.9% | $1.8M | 2025-Q3 |
| MORGAN STANLEY | ADD | 1,128,311 | 2,190,676 | +94.2% | $30.6M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 1,068,120 | 750,447 | -29.7% | $10.5M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 295,020 | 684,612 | +132.1% | $9.6M | 2025-Q2 |
| UBS Group AG | NEAR_EXIT | 1,516,255 | 289,345 | -80.9% | $4.0M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | ADD | 208,473 | 280,733 | +34.7% | $3.9M | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | TRIM | 127,274 | 73,014 | -42.6% | $1.0M | 2025-Q2 |
| FMR LLC | TRIM | 21,576 | 15,427 | -28.5% | $215.5K | 2025-Q2 |
| UBS Group AG | ADD | 824,423 | 1,516,255 | +83.9% | $22.4M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 1,449,786 | 1,068,120 | -26.3% | $15.8M | 2025-Q1 |
| CITADEL ADVISORS LLC | ADD | 416,351 | 735,573 | +76.7% | $10.9M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 498,405 | 208,473 | -58.2% | $3.1M | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 45,942 | 127,274 | +177.0% | $1.9M | 2025-Q1 |
| FMR LLC | ADD | 13,180 | 21,576 | +63.7% | $318.7K | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 1,449,786 | — | $11.9M | 2024-Q4 |
| MORGAN STANLEY | TRIM | 2,826,510 | 1,003,506 | -64.5% | $8.2M | 2024-Q4 |
| UBS Group AG | DOUBLED | 125,380 | 824,423 | +557.5% | $6.8M | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 6.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Oct 2025): 82% buy across 11 analysts — 2 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Oct 2025. No current recommendation available.
$23.01 mean target (Oct 2025)
$20.04 Low
$27.00 High
| Metric | Value |
|---|---|
| Current Price | $15.02 |
| Target Low | $20.04 |
| Target Mean | $23.01 |
| Target Median | $22.00 |
| Target High | $27.00 |
| # Analysts | 3 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-06-30 |
$2.85 | $2.74 | $2.96 | 121.0% | +1.6% | 2↑ 0↓ | $98.9B | 33.9% | 2 |
| Next FY 2027-06-30 |
$3.32 | $3.32 | $3.32 | 16.4% | +0.0% | 1↑ 0↓ | $124.0B | 25.3% | 1 |
10 analyst firms have rated this stock: 9 upgrades, 14 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Oct 9, 2025 | HSBC | UPGRADE | Hold | Buy |
| Jul 17, 2025 | BMO Capital | INITIATE | — | Market Perform |
| Nov 12, 2024 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Oct 10, 2024 | JP Morgan | UPGRADE | Underweight | Neutral |
| Jul 3, 2024 | JP Morgan | MAINTAIN | Underweight | Underweight |
| May 28, 2024 | JP Morgan | MAINTAIN | Underweight | Underweight |
| Apr 19, 2024 | HSBC | DOWNGRADE | Hold | Reduce |
| Apr 17, 2024 | JP Morgan | MAINTAIN | Underweight | Underweight |
| Oct 12, 2023 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Sep 29, 2023 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Sep 7, 2022 | UBS | DOWNGRADE | Buy | Neutral |
| Apr 4, 2022 | JP Morgan | MAINTAIN | — | Neutral |
| Sep 12, 2019 | JP Morgan | MAINTAIN | — | Overweight |
| Feb 21, 2019 | JP Morgan | UPGRADE | Underweight | Overweight |
| Aug 28, 2018 | Macquarie | DOWNGRADE | Neutral | Underperform |
| Oct 20, 2017 | B of A Securities | DOWNGRADE | Buy | Neutral |
| Mar 3, 2017 | JP Morgan | DOWNGRADE | Overweight | Underweight |
| Nov 11, 2016 | Morgan Stanley | UPGRADE | Underweight | Equal-Weight |
| Nov 11, 2016 | Citigroup | DOWNGRADE | Neutral | Sell |
| Nov 11, 2016 | HSBC | DOWNGRADE | Buy | Hold |
| Jul 12, 2016 | JP Morgan | UPGRADE | Neutral | Overweight |
| Jul 5, 2016 | Macquarie | UPGRADE | Underperform | Neutral |
| Jul 1, 2016 | Macquarie | UPGRADE | Underperform | Neutral |
| Mar 15, 2016 | Macquarie | DOWNGRADE | Neutral | Underperform |
| Oct 22, 2013 | Goldman Sachs | UPGRADE | Sell | Neutral |
| Sep 13, 2013 | Goldman Sachs | DOWNGRADE | Neutral | Sell |
| Sep 12, 2013 | JP Morgan | UPGRADE | Neutral | Overweight |
| Aug 21, 2013 | UBS | DOWNGRADE | Neutral | Sell |
| Aug 8, 2013 | HSBC | DOWNGRADE | Neutral | Underweight |
| Jan 24, 2013 | CIBC | DOWNGRADE | Sector Outperform | Sector Perform |
| Sep 25, 2012 | Morgan Stanley | DOWNGRADE | Equal-Weight | Underweight |
| Sep 6, 2012 | JP Morgan | DOWNGRADE | Overweight | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| May 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Apr 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% | |
| Mar 1, 2026 | 2 | 5 | 4 | 0 | 0 | 64% | |
| Feb 1, 2026 | 1 | 6 | 4 | 0 | 0 | 64% | |
| Jan 1, 2026 | 1 | 6 | 3 | 1 | 0 | 64% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 9, 2026
short_volume
Short Volume: HMY — 61.1% short (0.7M / 1.2M)
Short: 710,592 | Exempt: 25 | TRF Vol: 1,162,084 | Short Ratio: 61.1% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
short_volume
Short Volume: HMY — 61.0% short (1.3M / 2.1M)
Short: 1,283,181 | Exempt: 16,646 | TRF Vol: 2,103,693 | Short Ratio: 61.0% | Off-exchange volume (dark pool + OTC)
Jun 4, 2026
short_volume
Short Volume: HMY — 56.6% short (0.3M / 0.5M)
Short: 299,670 | Exempt: 50 | TRF Vol: 529,525 | Short Ratio: 56.6% | Off-exchange volume (dark pool + OTC)
Jun 3, 2026
short_volume
Short Volume: HMY — 59.0% short (0.4M / 0.6M)
Short: 375,369 | Exempt: 8,170 | TRF Vol: 636,477 | Short Ratio: 59.0% | Off-exchange volume (dark pool + OTC)
Jun 2, 2026
short_volume
Short Volume: HMY — 67.2% short (0.6M / 0.9M)
Short: 572,609 | Exempt: 738 | TRF Vol: 851,815 | Short Ratio: 67.2% | Off-exchange volume (dark pool + OTC)
May 29, 2026
short_volume
Short Volume: HMY — 57.3% short (0.6M / 1.1M)
Short: 608,531 | Exempt: 0 | TRF Vol: 1,061,729 | Short Ratio: 57.3% | Off-exchange volume (dark pool + OTC)
May 28, 2026
short_volume
Short Volume: HMY — 74.5% short (0.9M / 1.2M)
Short: 897,495 | Exempt: 3,024 | TRF Vol: 1,205,182 | Short Ratio: 74.5% | Off-exchange volume (dark pool + OTC)
May 27, 2026
short_volume
Short Volume: HMY — 63.5% short (0.5M / 0.9M)
Short: 545,735 | Exempt: 1,733 | TRF Vol: 859,551 | Short Ratio: 63.5% | Off-exchange volume (dark pool + OTC)
May 26, 2026
short_volume
Short Volume: HMY — 55.2% short (0.8M / 1.4M)
Short: 782,605 | Exempt: 425 | TRF Vol: 1,417,310 | Short Ratio: 55.2% | Off-exchange volume (dark pool + OTC)
May 22, 2026
short_volume
Short Volume: HMY — 56.5% short (0.3M / 0.6M)
Short: 312,859 | Exempt: 49 | TRF Vol: 553,793 | Short Ratio: 56.5% | Off-exchange volume (dark pool + OTC)
May 21, 2026
short_volume
Short Volume: HMY — 68.0% short (0.8M / 1.1M)
Short: 751,793 | Exempt: 151 | TRF Vol: 1,105,858 | Short Ratio: 68.0% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: HMY — 71.9% short (1.1M / 1.6M)
Short: 1,144,010 | Exempt: 2,809 | TRF Vol: 1,591,450 | Short Ratio: 71.9% | Off-exchange volume (dark pool + OTC)
May 19, 2026
short_volume
Short Volume: HMY — 67.0% short (1.3M / 1.9M)
Short: 1,297,518 | Exempt: 11 | TRF Vol: 1,936,991 | Short Ratio: 67.0% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: HMY — 57.6% short (0.8M / 1.3M)
Short: 765,590 | Exempt: 8 | TRF Vol: 1,330,085 | Short Ratio: 57.6% | Off-exchange volume (dark pool + OTC)
May 14, 2026
short_volume
Short Volume: HMY — 72.1% short (0.4M / 0.6M)
Short: 426,000 | Exempt: 1,390 | TRF Vol: 591,161 | Short Ratio: 72.1% | Off-exchange volume (dark pool + OTC)
May 13, 2026
Clinical Trial
A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
Phase Phase 2 — COMPLETED